Dermapharm Holding SE

  • WKN: A2GS5D
  • ISIN: DE000A2GS5D8
  • Land: Deutschland

Nachricht vom 16.05.2019 | 16:17

Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Dermapharm Holding SE / Preliminary announcement on the disclosure of
financial statements

16.05.2019 / 16:17
Preliminary announcement of the publication of quarterly reports and
quarterly/interim statements transmitted by DGAP - a service of EQS Group
AG.
The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed : Report: Quarterly/ Interim statement within the 1st half-year Date of disclosure / German: May 21, 2019 Date of disclosure / English: May 21, 2019 German: https://ir.dermapharm.de/#Finanzberichte English: https://ir.dermapharm.de/index-EN.php#Finanzberichte
16.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: Dermapharm Holding SE Lil-Dagover-Ring 7 82031 Grünwald Germany Internet: ir.dermapharm.de End of News DGAP News Service